Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Pralsetinib is indicated for the treatment of patients with metastatic (spread) ···【more】
Release date：2026-01-15Recommended：204
Pralsetinib is indicated for the treatment of patients with advanced or metastat···【more】
Release date：2026-01-15Recommended：249
As a novel AKT inhibitor, the drug interactions of capivasertib represent a crit···【more】
Release date：2026-01-13Recommended：267
Although capivasertib offers a new treatment option for specific cancers, its ef···【more】
Release date：2026-01-13Recommended：255
Do not take other medications unless you have discussed them with your doctor. T···【more】
Release date：2026-01-13Recommended：286
This medicine may affect your blood glucose levels. If you experience increased ···【more】
Release date：2026-01-13Recommended：296
Capivasertib (trade name: Truqap) is an oral pan-AKT inhibitor. In combination w···【more】
Release date：2026-01-13Recommended：283
Capivasertib (trade name: Truqap) is the world’s first approved AKT inhibitor ta···【more】
Release date：2026-01-13Recommended：254
Capivasertib is an investigational serine/threonine kinase (AKT) inhibitor.Is Ca···【more】
Release date：2026-01-13Recommended：282
Capivasertib is an oral kinase inhibitor that targets all three isoforms of the ···【more】
Release date：2026-01-13Recommended：339
Drugs used to treat cancer are usually highly potent and may cause numerous side···【more】
Release date：2026-01-13Recommended：323
Capivasertib (trade name: Truqap) is the world’s first approved AKT protein kina···【more】
Release date：2026-01-13Recommended：222
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
